Bulmer L, Ljungman C, Hallin J, Dahlberg P, Polte C, Hedberg-Oldfors C
Eur J Hum Genet. 2025; .
PMID: 40065010
DOI: 10.1038/s41431-025-01827-8.
Schubert S, Ruano D, Joruiz S, Stroosma J, Glavak N, Montali A
Nat Commun. 2024; 15(1):8208.
PMID: 39294166
PMC: 11410958.
DOI: 10.1038/s41467-024-52551-8.
Parsons M, de la Hoya M, Richardson M, Tudini E, Anderson M, Berkofsky-Fessler W
Am J Hum Genet. 2024; 111(9):2044-2058.
PMID: 39142283
PMC: 11393667.
DOI: 10.1016/j.ajhg.2024.07.013.
Zanti M, OMahony D, Parsons M, Li H, Dennis J, Aittomakkiki K
Hum Mutat. 2024; 2023.
PMID: 38725546
PMC: 11080979.
DOI: 10.1155/2023/9961341.
Carrizosa C, Undlien D, Vigeland M
Bioinformatics. 2024; 40(5).
PMID: 38598476
PMC: 11069105.
DOI: 10.1093/bioinformatics/btae201.
ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification.
Biesecker L, Byrne A, Harrison S, Pesaran T, Schaffer A, Shirts B
Am J Hum Genet. 2023; 111(1):24-38.
PMID: 38103548
PMC: 10806742.
DOI: 10.1016/j.ajhg.2023.11.009.
Specifications of the ACMG/AMP Variant Classification Guidelines for Germline Variant Curation.
Hatton J, Frone M, Cox H, Crowley S, Hiraki S, Yokoyama N
Hum Mutat. 2023; 2023.
PMID: 38084291
PMC: 10713350.
DOI: 10.1155/2023/9537832.
A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
Bjornstad P, Aalokken R, Asheim J, Sundaram A, Felde C, Ostby G
Eur J Hum Genet. 2023; 32(5):513-520.
PMID: 38030917
PMC: 11061271.
DOI: 10.1038/s41431-023-01494-7.
The effect of ascertainment on penetrance estimates for rare variants: Implications for establishing pathogenicity and for genetic counselling.
Paterson A, Seok S, Vieland V
PLoS One. 2023; 18(9):e0290336.
PMID: 37733810
PMC: 10513297.
DOI: 10.1371/journal.pone.0290336.
Multicenter clinical and functional evidence reclassifies a recurrent noncanonical filamin C splice-altering variant.
ONeill M, Chen S, Rumping L, Johnson R, van Slegtenhorst M, Glazer A
Heart Rhythm. 2023; 20(8):1158-1166.
PMID: 37164047
PMC: 10530503.
DOI: 10.1016/j.hrthm.2023.05.006.
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Thomassen M, Mesman R, Hansen T, Menendez M, Rossing M, Esteban-Sanchez A
Hum Mutat. 2022; 43(12):1921-1944.
PMID: 35979650
PMC: 10946542.
DOI: 10.1002/humu.24449.
Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.
Clark K, Paquette A, Tao K, Bell R, Boyle J, Rosenthal J
Am J Hum Genet. 2022; 109(6):1153-1174.
PMID: 35659930
PMC: 9247830.
DOI: 10.1016/j.ajhg.2022.05.004.
An algorithm for optimal testing in co-segregation analysis.
Buie R, Ranola J, Chen A, Shirts B
Hum Mutat. 2022; 43(5):547-556.
PMID: 35225377
PMC: 9018554.
DOI: 10.1002/humu.24363.
Value of the loss of heterozygosity to BRCA1 variant classification.
Santana Dos Santos E, Spurdle A, Carraro D, Briaux A, Southey M, Torrezan G
NPJ Breast Cancer. 2022; 8(1):9.
PMID: 35039532
PMC: 8764043.
DOI: 10.1038/s41523-021-00361-2.
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L
Genet Med. 2021; 24(1):119-129.
PMID: 34906479
PMC: 10170303.
DOI: 10.1016/j.gim.2021.08.016.
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Caputo S, Golmard L, Leone M, Damiola F, Guillaud-Bataille M, Revillion F
Am J Hum Genet. 2021; 108(10):1907-1923.
PMID: 34597585
PMC: 8546044.
DOI: 10.1016/j.ajhg.2021.09.003.
5' Region Large Genomic Rearrangements in the Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints.
Caputo S, Telly D, Briaux A, Sesen J, Ceppi M, Bonnet F
Cancers (Basel). 2021; 13(13).
PMID: 34202044
PMC: 8268747.
DOI: 10.3390/cancers13133171.
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.
Li N, Zethoven M, McInerny S, Devereux L, Huang Y, Thio N
NPJ Breast Cancer. 2021; 7(1):52.
PMID: 33980861
PMC: 8115524.
DOI: 10.1038/s41523-021-00255-3.
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
Parsons M, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadalo L
Hum Mutat. 2019; 40(9):1557-1578.
PMID: 31131967
PMC: 6772163.
DOI: 10.1002/humu.23818.
Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?.
Zuntini R, Ferrari S, Bonora E, Buscherini F, Bertonazzi B, Grippa M
Front Genet. 2018; 9:378.
PMID: 30254663
PMC: 6141711.
DOI: 10.3389/fgene.2018.00378.